2026 funding rounds and state support across AI, robotics and biotech
Recent capital raises and government contracts highlight investment activity in artificial intelligence, robotics and biotechnology during 2026.
ai · robotics · biology
Briefings
Funding, investment and industrial activity across the three fields Hyperuranios backs. Compiled daily from reported sources, every claim linked to the article it came from. Published in English only.
-
-
Lyte raises $165m and multiple large robotics funding rounds announced in 2026
Series C financing for Lyte and sizable investments in Motion, Sharpa, and Xpeng illustrate growing capital for physical AI and humanoid robot platforms, alongside Y Combinator directories of AI and biotech startups.
robotics · biology
-
Cognition AI $1bn raise, Flower Labs model launch, AI data centre $75bn spend
Recent months saw major AI funding rounds, a surge in data‑centre construction spending, and notable robotics and biotech investments across the globe.
ai · robotics · biology
-
Major funding rounds in AI‑driven biotech, synthetic biology and humanoid robotics in 2026
Large capital inflows highlighted AI‑focused biotech, concentrated synthetic‑biology investment and a surge in humanoid‑robotics financing.
biology
-
2026 venture funding highlights: biotech AI, lab AI platforms and humanoid robotics
A roundup of 2026 financing activity across biotech, artificial‑intelligence lab platforms and humanoid robotics, detailing investors, amounts and strategic aims.
ai · robotics
-
XPeng secures $900m for IRON robot amid Chinese government boost and YC robotics cohort
In August 2026 XPeng raised over $900 million to launch its IRON humanoid robot, China’s state bodies committed $230 million to humanoid procurement, and Y Combinator funded a wave of robotics startups targeting data, control and deployment challenges.
robotics
-
Major Funding Rounds Across Biotech, AI Agents and Humanoid Robotics in August 2026
In August 2026, eight biotech firms, an AI‑agent startup and several robotics companies secured multi‑hundred‑million‑dollar rounds to advance therapies, AI services and humanoid robot production.
robotics
-
Series Funding Across AI, Robotics and Gene‑Therapy Sectors in Mid‑2026
Recent rounds raised tens to hundreds of millions for AI health platforms, humanoid robotics production, and gene‑therapy development, detailing investors, amounts and intended use.
ai · robotics
-
Series B and Seed Rounds Fuel AI Health Platforms, Robotics Foundations and Clinical Data Infrastructure
Recent funding rounds across AI, robotics and biology bring capital to revenue‑assurance AI, lab‑digitisation, agentic AI, robot foundation models, humanoid robotics and global clinical data networks.
ai · robotics · biology
-
Major AI, Robotics and Biotech Funding Rounds and Market Signals August 2026
In August 2026 a series of large capital raises, insider purchases and industry forecasts highlighted growing investment in AI infrastructure, general‑purpose robotics and AI‑enabled biotech.
ai · robotics · biology
-
Nvidia backs Poolside with $7bn and XPeng secures $900m for humanoid robots
In August 2026 Nvidia committed $7bn to open‑source AI startup Poolside, while Chinese EV maker XPeng raised over $900m to mass‑produce its IRON humanoid robot; other AI and biotech startups also saw activity.
ai · robotics
-
AI funding round highlights Idler seed, Alibaba placement, Nvidia deals and SoftBank bond
Recent capital raises and acquisitions across AI and robotics illustrate diverse financing strategies from seed rounds to multi‑billion‑dollar placements.
ai
-
AI data‑center investment forecast and Unitree Robotics IPO reshape capital allocation
Recent reports detail a $3 trillion AI‑driven data‑center capex outlook, a growing AI data‑pipeline market, and a $905 million Shanghai IPO for Unitree Robotics.
ai
-
Series of AI, Robotics and Bio‑Tech Funding and Strategic Deals in Mid‑2026
Mid‑2026 saw major capital raises, licensing agreements and acquisitions across AI data services, AI coding platforms, enterprise AI consultancies, robotics startups and AI‑driven biotech ventures.
ai · robotics · biology
-
Funding rounds in AI wearables, humanoid robotics, and AI-driven biology in 2026
Recent 2026 financing events include a $2 m pre‑seed for AI lab wearables, a €1 bn raise for a German humanoid robot maker, a $1.8 bn loan for SoftBank’s robotics acquisition, and a $20 m round valuing an AI‑biology startup at $3.8 bn.
ai · robotics · biology
-
Seed $90M for World‑Model AI, $100B Nvidia‑OpenAI pact and $200M robotics round
Q3 2026 saw large seed and strategic investments in physical AI, a $100 billion Nvidia‑OpenAI partnership, a $200 million construction‑robotics round, a Chinese humanoid robot IPO, a North Carolina VC surge and Y Combinator’s drug‑discovery cohort.
ai · robotics
-
AI, Robotics and Biotech Funding Activity in August 2026
A roundup of major financing rounds across artificial intelligence, robotics and biotechnology reported in August 2026.
ai · robotics · biology
-
Finster AI Series B, Unitree IPO, Gravis Robotics Series A, Harell Data $15m raise
Recent financing activity spans AI platforms for finance, a Chinese humanoid robot IPO, a European construction‑robotics unicorn, and a data‑exchange startup for biotech AI.
ai · robotics
-
AI Funding, Data‑Centre Investment and Early‑Stage Startup Activity in 2026
Recent financing rounds, data‑centre spending and early‑stage ventures highlight activity across AI, robotics and biotech in 2026.
ai
-
Major AI Infrastructure and Market Moves in 2025‑2026
Funding, acquisitions and pricing shifts reshape AI compute, tools and investment landscape.
ai
-
2026 Funding Rounds and Strategic Moves Across AI, Robotics and Biotechnology
A roundup of major financing events and corporate actions in AI, robotics and biotech during August 2026.
ai · robotics
-
AI, robotics and biotech funding and market activity in August 2026
Recent seed, series and IPO rounds across AI, robotics and biotech illustrate capital deployment into model development, automation and gene‑editing therapies.
ai · robotics · biology
-
AI and robotics firms raise billions in funding and M&A activity in August 2026
In August 2026, AI‑focused private equity, venture‑backed code‑generation and science startups secured large rounds, while robotics saw multiple large‑scale investments, acquisitions and seed financings, and a UK biotech raised capital for cell‑gene therapy.
ai · robotics · biology
-
AI, robotics and biotech rounds raise over $1bn in August 2026
Multiple funding events across artificial intelligence, robotics and biotechnology saw significant capital deployment in August 2026, highlighting expanding investor interest in specialised platforms and models.
ai · robotics · biology
-
AI funding concentration and notable biotech and robotics financing in H1 2026
The first half of 2026 saw $407 bn poured into AI, a $100 m Series B for AI‑driven drug design, OpenAI’s $7 bn employee buy‑back, a robotics acquisition, a Unitree IPO, and a $14.7 m seed round for ocular gene therapy.
ai · robotics · biology
-
2026 Robotics Funding, M&A and Public Listing Activity
In August 2026 a range of robotics startups were profiled, analysts highlighted key automation stocks, major robot firms were acquired, and Agility Robotics announced a $2.5bn SPAC merger, while Y Combinator listed dozens of AI‑driven biotech startups.
robotics
-
Google AI founders launch Discovery Loop; US hardware startups raise $2.4bn; CRISPR rare‑disease trials progress
Recent reports detail Alphabet’s backing of a new AI research venture, multi‑billion‑dollar funding for automated factories and nuclear reactors, a seed round for an AI sales‑agent platform, YC’s 2026 AI and robotics cohorts, and advancing in‑vivo CRISPR therapies for rare diseases.
ai
-
Accenture acquires Faculty for $1B and Malachyte raises $10M seed round
In June 2026 Accenture bought UK AI firm Faculty for $1 billion, while in August 2024 Malachyte secured a $10 million seed round to expand its real‑time e‑commerce personalisation platform.
ai
-
Series A, seed and acquisition deals drive AI, robotics and biotech activity in August 2026
Recent funding rounds, a major acquisition and partnership announcements highlight investment and development trends in artificial intelligence, industrial robotics and biopharmaceuticals.
ai · robotics · biology
-
2026 Funding Rounds Across AI, Robotics and Genetic Engineering
The cycle records multiple capital raises and strategic deals in AI, robotics and gene‑editing, detailing amounts, investors and intended uses.
ai · robotics · biology
-
Major AI, Robotics and Biotech Funding Rounds in H2 2026
Recent financing activity saw multi‑hundred‑million investments in AI hardware, large AI fundraisings, humanoid‑robot valuations and early‑stage biotech gene‑editing programmes.
ai · robotics · biology
-
Startups raise $1.5bn; Microsoft to invest $80bn in data centres; CRISPR shows safety
July saw Israeli AI firms secure $1.5bn, Microsoft announced an $80bn AI data‑centre spend, and a CRISPR stem‑cell transplant trial reported safety in AML patients.
ai
-
2026 H1 Global AI Funding Peaks, Robotics Consolidations, and Gene‑Editing Research Highlights
In H1 2026 AI venture capital reached a record $510 billion, robotics firms pursued strategic acquisitions in India and warehouse automation, and ScienceDaily reported new gene‑editing research.
robotics
-
European AI policy, Microsoft data‑center spend and multiple AI startup fundings in 2026
2026 saw the EU roll out its AI Continent Action Plan, Microsoft commit $80bn to AI‑focused data centres, and several AI‑driven startups secure seed and growth capital, while GenePlanet raised strategic funding for genomics expansion.
ai · biology
-
2026 funding rounds and infrastructure bets across AI, robotics and biotech
Series A to Series C rounds, major data‑center commitments and biotech IPOs mark a busy investment period in artificial intelligence, robotics and genetics.
ai · robotics
-
2026 AI and Robotics Funding Rounds and Infrastructure Investments
The cycle includes seed to series rounds for AI platforms, large AI infrastructure financing, multiple robotics startups raising capital, and a biotech seed round for mitochondrial therapeutics.
ai · robotics · biology
-
DeepSeek pauses $71bn round and Humanoid secures $152m Series A in 2026
Mid‑2026 saw a high‑profile Chinese AI lab halt a multibillion‑dollar raise and a London robotics start‑up close a substantial Series A backed by European industrial groups.
ai · robotics
-
Series funding rounds boost AI coding, humanoid robotics and agri‑biotech startups
Mid‑2026 rounds raise capital for Emergent, Humanoid, Monumental, Moa Technology and healthtech firms.
ai · robotics · biology
-
Recent Funding Rounds Across AI, Robotics and Agri‑Biotech: Seed to Unicorn
The cycle saw €12 m seed for a German reasoning‑first AI lab, $8 m seed for a Korean‑US drug‑discovery AI, $152 m Series A unicorn for a UK humanoid robot maker, $100 m raise for a Chinese embodied‑AI startup, and €25.9 m Series C for a UK agri‑biotech firm.
ai · robotics · biology
-
Humanoid Series A, Atoms $1.7bn raise and biotech seed rounds announced
Series A for Humanoid, a $1.7bn raise by Atoms, a SoftBank loan for ABB robotics, and seed funding for Phoenix Lab and Colossal Biosciences highlight recent capital moves in robotics and biotech.
robotics · biology